FKBP4 and central nervous system cancer: Conversely, Yang et al. (2015) demonstrated that the full-length FKBP51 (isoform 1) suppresses glioma growth by increasing Bcl-2 expression and decreasing Bax, and cleaved caspase-3 and caspase-9, thereby hindering cell growth and promoting apoptosis.